Discovery Research Articles
-
Driving Rapid Development Of Complex Biologics
11/6/2025
To accommodate the cell expression needs of mAbs, bispecifics, and other advanced multi-specific antibodies, sponsors must leverage a cell line development platform proven to support these modalities. That’s why KBI Biopharma designed the TranspoEase platform to provide high titer and high stability cell line expression for complex proteins.
-
Discover Our iPSC Differentiated Cell Services
9/30/2025
iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.
-
The Essential Role Of High-Quality Anti-Host Cell Protein (HCP) Antibody Reagents
9/13/2025
Advance biopharmaceutical development with robust HCP detection strategies and high-quality antibody reagents to ensure product purity, safety, and regulatory compliance.
-
Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod
9/8/2025
To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.
-
Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity
9/8/2025
Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.
-
Scalable Production Of High-Purity Nanobodies Using Yeast Expression System
9/8/2025
Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.
-
Paclitaxel-Induced Peripheral Neuropathic Pain Model
9/8/2025
Utilize paclitaxel-induced animal models to advance research and develop effective therapies for human neuropathic pain.
-
Random And Semi-Targeted Integration In Cell Line Development
8/5/2025
While semi-targeted approaches may offer precision, uncover how they may fall short in overall efficiency and productivity, especially in late-stage manufacturing.
-
In Vivo Pharmacology
6/20/2025
Partner with us for ethically conducted, IAEC-approved studies in AAALAC- and CPCSEA-accredited facilities, using quality animals from Taconic and Charles River.
-
Discovery Biology Solutions
6/20/2025
Our capabilities span cell and protein sciences, high-throughput screening, assay development, biomarker validation, radiometric assays, DMPK, animal pharmacology, and exploratory toxicology.